The Santa Rosa Memorial Hospital CCOP(SRMH CCOP) is the result of intensive development by a core group of oncologists who serve 80% of the cancer patients in a relatively isolated five county area in Northern California. The sixteen medical and radiation oncologists who form the Redwood Regional Medical Group see over 2800 new patients per year. Two new affiliate sites have joined the SRMH CCOP during the last funding period, bringing an additional five oncologists and expanding the geographic catchment area thus ensuring an adequate patient population for clinical trials accrual. The SRMH CCOP provides the support needed to increase access to the latest cancer treatment and control research protocols in the five counties it serves. The patient population includes a significant number of underserved rural, ethnic and socio-economically disadvantaged individuals for whom the CCOP provides access to state-of-the-art treatment. Our program has systematically assembled the necessary resources: highly trained oncologists, an expert data management staff experienced with cooperative group clinical trials, high quality control standards, hospital resource commitments and involvement of non-oncology specialists. The clinical research team has developed an effective case-finding approach which ensures achievement of CCOP goals. Of particular note is the program's highly successful track record in cancer control accrual resulting in 168 persons being registered to the PCPT trial and 40 patients registered to the STAR trial. As a designated SELECT site, we have registered 28 patients to the study this year. The CCOP plans to register a minimum of 40 patients to SELECT and 10 patients to STAR this year.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10CA063850-12S1
Application #
7258588
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Kelaghan, Joseph
Project Start
1994-08-26
Project End
2008-05-31
Budget Start
2006-06-01
Budget End
2008-05-31
Support Year
12
Fiscal Year
2006
Total Cost
$244,912
Indirect Cost
Name
Santa Rosa Memorial Hospital
Department
Type
DUNS #
023104438
City
Santa Rosa
State
CA
Country
United States
Zip Code
95403
Heinrich, Michael C; Rankin, Cathryn; Blanke, Charles D et al. (2017) Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. JAMA Oncol 3:944-952
Wozniak, Antoinette J; Moon, James; Thomas Jr, Charles R et al. (2015) A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533. Clin Lung Cancer 16:340-7
Erba, Harry P; Othus, Megan; Walter, Roland B et al. (2014) Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432. Leuk Res 38:329-33
Mehta, Rita S; Barlow, William E; Albain, Kathy S et al. (2012) Combination anastrozole and fulvestrant in metastatic breast cancer. N Engl J Med 367:435-44
Tomblyn, Michael B; Goldman, Bryan H; Thomas Jr, Charles R et al. (2012) Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414). J Thorac Oncol 7:906-12
Marshall, James R; Tangen, Catherine M; Sakr, Wael A et al. (2011) Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) 4:1761-9
Chu, David Z J; Hussey, Michael A; Alberts, David S et al. (2011) Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions. Clin Colorectal Cancer 10:310-6
Herbst, Roy S; Kelly, Karen; Chansky, Kari et al. (2010) Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342. J Clin Oncol 28:4747-54
Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST) (2010) Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol 28:1247-53
Gitlitz, Barbara J; Moon, James; Glisson, Bonnie S et al. (2010) Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial. J Thorac Oncol 5:1835-40

Showing the most recent 10 out of 63 publications